Zobrazeno 1 - 10
of 38
pro vyhledávání: ''
Autor:
Sylvie Bernaerts, Kaat Alaerts
Publikováno v:
European Neuropsychopharmacology. 29:S358-S359
Publikováno v:
European Neuropsychopharmacology. 24:553-563
A randomised placebo-controlled "dose relation study" was conducted in 549 patients who met the criteria for major depressive disorder, to evaluate the efficacy and safety of three doses regimens of agomelatine during 6 weeks: low fixed dosage (10 mg
Publikováno v:
European Neuropsychopharmacology. 23:645-652
Cholecystokinin-tetrapeptide (CCK-4)-induced panic attacks are reportedly attenuated by effective treatment with antipanic antidepressants in patients with panic disorder, but in healthy volunteers such effects are not well studied. The aim of this s
Publikováno v:
European Neuropsychopharmacology. 20:823-828
Reducing both glutamatergic and dopaminergic drive in the nucleus accumbens may offer complementary mechanisms by which to reduce drug cravings. This 8-week study sought to examine the efficacy of a combination of a glutamate modulator, N-acetyl cyst
Publikováno v:
European Neuropsychopharmacology. 9:S113-S117
Several case reports and open studies have reported the efficacy of lamotrigine in bipolar depression. A randomised placebo-controlled 7-week study comparing two doses of lamotrigine with placebo in 195 patients with moderate to severe bipolar depres
Publikováno v:
European Neuropsychopharmacology. 6:S4-150
Autor:
G. Stevens, C. Prinsze
Publikováno v:
European Neuropsychopharmacology. 6:S4-73
Publikováno v:
European Neuropsychopharmacology. 6:S4-144
Autor:
Massimiliano Buoli, A. Albano, Beatrice Benatti, I. Balossi, S. Bortolussi, Alfredo Carlo Altamura, Lucio Oldani, Bernardo Dell'Osso
Publikováno v:
European Neuropsychopharmacology. 19:S408-S409
Publikováno v:
European Neuropsychopharmacology. 19:S593-S594